Kynurenines, Neuropsychiatric Symptoms, and Cognitive Prognosis in Patients with Mild Dementia.

Solvang, Stein-Erik Hafstad; Nordrehaug, Jan Erik; Aarsland, Dag; Lange, Johannes; Ueland, Per Magne; McCann, Adrian; Midttun, Øivind; Tell, Grethe S; Giil, Lasse Melvaer

Solvang, Stein-Erik Hafstad; Nordrehaug, Jan Erik; Aarsland, Dag; Lange, Johannes; Ueland, Per Magne; McCann, Adrian; Midttun, Øivind; Tell, Grethe S; Giil, Lasse Melvaer.

Afiliação

Solvang SH; Department of Internal Medicine, Haraldsplass Deaconess Hospital, Bergen, Norway.
Nordrehaug JE; Department of Clinical Science, University of Bergen, Bergen, Norway.
Aarsland D; Department of Internal Medicine, Haraldsplass Deaconess Hospital, Bergen, Norway.
Lange J; Department of Clinical Science, University of Bergen, Bergen, Norway.
Ueland PM; Department of Old Age Psychiatry, King's College University, London, UK.
McCann A; The Norwegian Centre for Movement Disorders, Stavanger University Hospital, Stavanger, Norway.
Midttun Ø; Centre for Organelle Research (CORE), University of Stavanger, Stavanger, Norway.
Tell GS; Bevital A/S, Bergen, Norway.
Giil LM; Bevital A/S, Bergen, Norway.

Int J Tryptophan Res ; 12: 1178646919877883, 2019.

Article em En | MEDLINE | ID: mdl-31632053

Palavras-chave

Alzheimer's disease; Kynurenines; Lewy body dementia; hallucinations; kynurenic acid; kynurenine; neuropsychiatric symptoms

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Int J Tryptophan Res Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Noruega

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google